Emerging Drugs of Abuse

Patterns of recreational drug use undergo constant change. Health care providers must remain vigilant and informed regarding emerging drugs of abuse to care better for their patients. There is also a role for improved surveillance and characterization of novel drugs. This report reviews the clinical manifestations and toxicity of several new drugs of abuse, including dextromethorphan, hallucinogenic tryptamines (including “Foxy Methoxy”), hallucinogenic amphetamines (including 2C-B and 2C-T-7), as well as the herbal hallucinogen, Salvia divinorum.